Clinical Trial

Statins and ARBs on Rheumatoid Activity

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2018 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Trial Details
NCT Number NCT03770702
Lead Sponsor Sherief Abd-Elsalam
Conditions Rheumatoid Arthritis
Enrollment 45 participants
Start Date 2018-10-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2018-12-10